SUITGLIP D (Dapagliflozin (5mg) + Sitagliptin (50mg))

Suitglip D 5mg/50mg Tablet is a combined therapy designed to assist in the management of blood glucose levels. This medication is intended for use alongside a balanced diet and regular physical activity to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus. Its primary function is to facilitate the effective use of insulin in the body, which in turn aids in reducing blood sugar concentrations. Administration of Suitglip D can be done with or without meals, allowing flexibility in your daily routine; however, it is advisable to take it at the same time each day for optimal results. The prescribing physician will determine the appropriate dosage, and it is critical not to discontinue use without prior consultation, as this may lead to elevated blood sugar levels and increase the risk of severe complications such as nephropathy and vision impairment. This therapeutic agent is only one aspect of a comprehensive treatment regimen that should also include dietary management, exercise, and weight control based on your healthcare provider’s recommendations. While using Suitglip D, maintaining hydration is essential, as it may help minimize the risk of potential dehydration. In some cases, patients might experience fungal infections in the genital area; therefore, adhering to proper hygiene practices is advisable.